Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP492787.RAB6v8aiSH0-4hnPJI0gVVJCmXNbazHGAZmSIBQf95Gtw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP492787.RAB6v8aiSH0-4hnPJI0gVVJCmXNbazHGAZmSIBQf95Gtw130_assertion type Assertion NP492787.RAB6v8aiSH0-4hnPJI0gVVJCmXNbazHGAZmSIBQf95Gtw130_head.
- NP492787.RAB6v8aiSH0-4hnPJI0gVVJCmXNbazHGAZmSIBQf95Gtw130_assertion description "[Hypodense activated eosinophils have been described in various diseases such as parasitic or allergic diseases, hypereosinophilic syndrome (HES) associated in some cases to myeloproliferative markers, and more recently described in patients undergoing recombinant IL2 treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492787.RAB6v8aiSH0-4hnPJI0gVVJCmXNbazHGAZmSIBQf95Gtw130_provenance.
- NP492787.RAB6v8aiSH0-4hnPJI0gVVJCmXNbazHGAZmSIBQf95Gtw130_assertion evidence source_evidence_literature NP492787.RAB6v8aiSH0-4hnPJI0gVVJCmXNbazHGAZmSIBQf95Gtw130_provenance.
- NP492787.RAB6v8aiSH0-4hnPJI0gVVJCmXNbazHGAZmSIBQf95Gtw130_assertion SIO_000772 2037012 NP492787.RAB6v8aiSH0-4hnPJI0gVVJCmXNbazHGAZmSIBQf95Gtw130_provenance.
- NP492787.RAB6v8aiSH0-4hnPJI0gVVJCmXNbazHGAZmSIBQf95Gtw130_assertion wasDerivedFrom befree-20150227 NP492787.RAB6v8aiSH0-4hnPJI0gVVJCmXNbazHGAZmSIBQf95Gtw130_provenance.
- NP492787.RAB6v8aiSH0-4hnPJI0gVVJCmXNbazHGAZmSIBQf95Gtw130_assertion wasGeneratedBy ECO_0000203 NP492787.RAB6v8aiSH0-4hnPJI0gVVJCmXNbazHGAZmSIBQf95Gtw130_provenance.